10 Stocks That Offer Growth, Dividends and Have Traded Higher in 2025

Seeking Alpha10:03 ET

Amgen, Franco-Nevada, Take-Two Interactive And More: CNBC's 'Final Trades'

Benzinga09:12 ET

Expert Outlook: Vertex Pharmaceuticals Through The Eyes Of 18 Analysts

Benzinga08:00 ET

Cantor Fitzgerald Assumes Vertex Pharmaceuticals at Overweight, Announces Price Target of $535

Benzinga07:51 ET · Ratings

Vertex Pharmaceuticals Analyst Ratings

Benzinga07:48 ET · Ratings

Trump Reportedly Weighing a Move to Cut U.S. Drug Prices to International Levels

Seeking Alpha07:48 ET